Contour BioSolutions Streamlines Biotech Manufacturing with Next-Gen Single-Use Components
Contour BioSolutions is introducing its business offerings to the pharmaceutical and biotech industries with the launch of a complete portfolio of polymer-based, single-use tees, elbows, reducing crosses, adaptors, valves, star clamps and caps. These components, as part of nine new patented product lines, can be assembled in myriad configurations by the customer for production purposes.
Pharmaceutical and biotechnology manufacturers seeking reliable single-use technology (SUT) components for bioprocessing can look to Contour BioSolutions for lead times that beat industry averages. The pharmaceutical sector struggles with supply chain bottlenecks, long lead times and the need for flexible solutions. Contour BioSolutions redefines the status quo, by drastically reducing lead times for SUT components.
The SUT components from Contour BioSolutions are lot traceable, double bagged, labeled and gamma safe for sterilization. All are certified animal-derived ingredient free. Parts are available in a wide range of the most common sizes.
All parts are fabricated using USP Class VI tested materials. Standard parts are available off the shelf for immediate shipment, while the company offers the capability to design and create tooling for custom parts for special applications.
A Tri-Clamp connection is standard, for a secure and leak-proof seal. The component design enables swift assembly to cut costs and supplies compatibility for integrating SUTs seamlessly into bioprocessing workflows.
Contour BioSolutions is being launched by industry veterans with decades of experience working on cutting-edge solutions tailored to the dynamic needs of the biotech sector. The main goals are quality, efficiency and enabling scalability for manufacturing processes.
Lou Bongiorno, who built his career in the bioprocessing sector over the past few decades creating products and streamlining processes, founded Contour BioSolutions. He said, “Our goal is to lead the market by providing flexible, innovative solutions that directly address our clients’ needs, with part availability that reduces traditional supply chain bottlenecks.”
Highlighting the importance of domestic manufacturing in a post-pandemic world
The COVID-19 pandemic underscored the vulnerabilities of global supply chains, highlighting the necessity for domestic manufacturing in the biotech sector. Contour Bio is proud to champion domestic production, providing a reliable supply of essential components within the United States.
“The pandemic revealed the critical importance of domestic manufacturing for industry stability and security,” comments Bongiorno. “We are dedicated to contributing to a more self-sufficient, dependable supply chain here at home.”
Single use technology provides the flexibility bioprocessing operations require to remain competitive in today’s rapidly shifting marketplace. SUTs allow for rapid scale-up or scale-down of production processes, minimize the risk of cross-contamination and facilitate process validation.
SUTs require a lower capital investment for a cost-effective means of manufacturing high-quality biopharmaceuticals, emerging therapies or clinical trial materials, for example. Cleaning requirements are reduced, and manufacturing flexibility increased. Their flexibility, scalability and cost-effectiveness make SUTs a particularly attractive option for startups and small to medium-sized enterprises in the biotechnology space.
About Contour BioSolutions
Contour BioSolutions specializes in pioneering single-use bioprocessing solutions. We develop unique, polymer-based products based on extensive experience in ASME-BPE compliance, utilizing USP Class VI tested materials. We are committed to supplying high-performance, flexible solutions that meet the highest industry benchmarks for quality and safety.
